Variables associated with malondialdehyde level in thalassemia major patients

  • Arum Gunarsih Department of Child Health, Medical School, University of Indonesia, Cipto Mangunkusumo Hospital, Jakarta
  • Pustika Amalia Department of Child Health, Medical School, University of Indonesia, Cipto Mangunkusumo Hospital, Jakarta
  • Imam Boediman Department of Child Health, Medical School, University of Indonesia, Cipto Mangunkusumo Hospital, Jakarta
DOI: https://doi.org/10.14238/pi52.3.2012.125-31
Keywords: thalassemia, oxidative stress, ferritin, malondialdehyde

Abstract

BackgmundThalassemia is the most cormnon hereditary haemolytic
anaemia in the world, including in Indonesia. The main treatment
for thalassemia is regular transfusions, but these are knO\vn to cause
iron overload. Moreover, iron overload in jJô€®thalassemia patients
generates oxygen free radicals and peroxidative lipid injury. Ferritin
serum concentration is used as indirect measurement of iron overload.
Malondialdehyde (MDA), a terminal compound oflipid peroxidation,
is used as an index of oxidative stress status.
Objective To assess the correlation between iron overload (serum
ferritin level) and MDA as a marker of oxidative stress in thalassemia
major patients.
Methods This c rossô€®sectional study was conducted at Cipto
Mangunkusumo Hospital, Jakarta, from Mayô€®June 2009. Subjects
were thalassemia major patients (homozygous jJô€®thalassemia or
jJô€®thalassemia;HbE) who received regular blood transfusions, ironô€®
chelation, and vitamin E as an antioxidant. Data was collected by hisô€®
toryô€®taking, physical examination, medical records, and questionnaires.
Blocd specimens were dra\Vll from the thalassemia major subjects before
transfusion and examined for serum ferritin and MDA levels.
Results Fiftyô€®five subjects Mth thalassemia major (34 homozygous
jJô€®thalassemia and 21 jJô€®thalassemia;HbE) were included in our
study. Mean serum ferritin level was 3693.2 (SD 21423),ug/L and
me811 MDA level was 0.641 (SD 0.283) nmolimL. No cor relation
was found between serum ferritin and MDA levels in thalassemia
major subjects (r=0.147, P=0.285). As additional results, this study
also showed no correlation between MDA to reguler vitamin E
consumption (r=0.277, P=0.028) as well as MDA and nutritional
status (F0371, Pô€¯0.()J4).
Conclusion There was no cor relation between serum ferritin level
and plasma MDA level in thalassemia major subjects, no cor relations
between MDA and regular vitamin E consumption, as well as MDA
and nutritional status. [paediatr Indones. 2012;52:125,31].

References

1. Rund D, Rachmilewitz E. jJ􀁥thalassemia. N Engl J Med.
2005 ;353 .1135-46.
2. Olivieri NF. The p-thalassemias. N Engl) Med. 1999;341.99-
110.
3. Advani R, Sorenson S, Shinar E, Lande W, RachmileMtz
E, Schrier SL. Characterization and comparison of the
red blood cell membrane damage in severe human a􀁥 and
p-thalassemia. Blood. 1992;79.1058-63.
4. Prevalensi talasemia terus naik [homepage on the Internet].
c2008 [cited 2009 January 20]. Available from. http.//www.
mediainJonesia.com/print.php? ar id= 19143.
5. Data of Thalassemia Center Cipto Mangunkusumo Hospital,
Jakarta, December 200S.
6. Higgs DR, Thein SL, Woods WG. The molecular pathology
of the thalassemias. In: Weatherall DJ, Clegg B, editors.
The thalassemia syndromes. 4th edition. London: Blackwell
Science; 2001. p. 133-91.
7. Livrea tvtA, Tesoriere L, Pintaudi AM, Calabrese A, Maggio
A, Freisleben HJ, et al. Oxidative stress and antioxidant status
in beta􀁥thalassemia major: iron overload and depletion of
lipid-soluble antioxidants. Blood. 1996;88.3608-14.
S. Das N, Das CT, Chattopadhyay A, Datta AG. Attenuation of
oxidative stress􀁥induced changes in thalassemic erythrocytes
by vitamin E. Pol) Pharmacol. 2004;56.85-96.
9. Kassab􀁥Chekir AK, Laradi S, Ferchicli S, Khelil AH, Feb
M, Amri F, et al. Oxidant, antioxidant status and metabolic
data in patients with beta􀁥thalassemia. Clin Chim Act.
2003;338;79-86.
10. Kattamis A, Papassotiriou I, Palaiologou D, Apostolakou F,
Galani A, Ladis V, et al. The effects of erythropoetic activity
and iron burden on hepcidin expression in patients Mth thalassemia major. Haematologica. 2006;91:S09􀁥12.
11. Laksmitawati DR, Handayani S, Udyaningsih SK, Kumiati V,
Adhiyanto C, HidayatJ, et al.lron status and oxidative stress
in jJ􀁥thalassemia patients in Jakarta. Bio Fac. 2003;19:53􀁥62.
12. Goswami K, Ghosh S, Bandyopadhyay, Mukherjee KL.lron
store and free radicals in thalassemia. IndianJ Clin Biochem.
2005;20.192A.
13. Ghone RA, Kumbar KM, Suryakar AN, Katkam RV, Joshi
NG. Oxidative stress and disturbance in antioxidant
balance in beta thalassemia major. Indian J Clin Biochem.
2008 ;23 .33 7-40.
14. Simsek F, Ozturk G, Kemahli S, Erbas D, Hasanoglu A.
Oxidant and antioxidant status in beta thalassemia major
patients. Ankara Universitesi Tip Fakultesi Mecmuasi.
2005;58.34-8.
15. Pavlova LE, Savov V M, Petkov HG, Charova IP. Oxidative
stress in patients with jJ􀁥thalassemia major. Sec Biol Med Sci.
2007 ;28. 145-54.
16. Meral A, Tuncel P, Surmen E, Ozbek R, Ozturk E, Gunay U.
Lipid peroxidation and antioxidant status in jJ􀁥thalassemia .
Ped Hem One. 2001;17.687-93.
17. Angelucci E, Brittenham GM, McLaren CE, Ripalti M,
Baronciani D, Giardiani C, et al. Hepatic iron concentration
and total body iron stores in thalassemia major. N EnglJ Med.
2000;343.327-31.
IS. Chigetti G, Duca L, Bortone L, Sala S, Nava L, Fiorelli G, et
al. Oxidative status and malondialdehyde in jJ􀁥thalassemia
patients. Eur J Clin Inves. 2002;32:55􀁥60.
19. Eposito BP, Breuer W, Sirankaprancha P, Pootrako C,
Cabantchik ZI. Labile plasma iron in iron overload:
redox activity and susceptibility to chelation. Blood.
2003;102.2670-7.
20. Naithani R, ChandraJ, BhattacharjeeJ, Verma P, Narayan S.
Peroxidative stress and antioxidant enzymes in children Mth
jJ􀁥thalassemia major. Pediatr Blood Cancer. 2006;46:7S0􀁥5.
21. Walter PB, Fung EB, Killilea DW, Jiang Q, Hudes M,
Madden J, et al. Oxidative stress and inflammation in iron
overloaded patients Mth jJ􀁥thalassemia or sickle cell disease.
Br) Haematol. 2006;135.254-63.
22. Widad NM, Al􀁥Naama LM, Hassan MK.lipid peroxidation
in beta􀁥thalassemia. Haema. 2006;9:374􀁥9.
23. Nourooz􀁥ZadehJ, Chiani M, Khadam MHA, Hejazi S. Plasma
measures of oxidative stress in jJ􀁥thalassemia. J Unnia Univ
Med Sci. 2005;16.118.
24. Nielsen F, Mikkelsen BB, Nielsen JB, Andersen HR,
Grandjean P. Plasma malondialdehyde as biomarker for
oxidative stress: reference interval and effects of life􀁥style
factors. Clin Chern. 1997;43.1209-14.
25. Data of T halassemia Center Cipto Mangunkusumo Hospital,
Jakarta, December 2005.
26. Wills, ED. Evaluation of lipid peroxidation in lipids and
biological membranes. In: Snell, K. and Mullock, B, editors.
Biochemical toxicology. A practical approach: practical
approach series. London: IRL press, Oxford; 1987. p.76􀁢84.
27. Englebienne P, Hoonacker AV , Valsamis J. Rapid homogeneous
immunoassay for human ferritin in the Cobas Mira using
colloidal gold as the reporter reagent. Clinical Chemistry.
2000;46,2000-3.
28. Modell B, Berdoukas V. Transfusion􀁢dependent thalassemia:
a new era. Med J Allst. 2008;188,68-9.
29. Constantoulakis M, Logothetis J, Loewenson RB, Augoustaki 0,
Economidov J. Bcdy growth in Cooley's anemia (homozygous
beta thalassemia) v.ith a correlative study as to other aspects of
illness in 138 cases. Pediatrics. 1972;50:92􀁢9.
30. Puspasad M. Kadar glutation and malondyaldehide
plasma darah mahasiswa Universitas Neged Jakarta.
[bachelor's thesis]. [Jakarta]: Universitas N egeri Jakarta;
2005.
31. Valko M, Leibfritz D, Moncol J, Cronin MTD, Mazur MJ,
Telser J. Free radicals and antioxidant in normal physiological
functions and human disease. Int J Biochem Cell Biol.
2007;39A4-84.
32. Herbert V, Jayatilleke E, Shaw S, Rosman AS, Giardina P,
Grady RW, et al. Serum ferritin iron, a new test, measures
human body iron stores unconfounded by inflammation.
Stem Cells. 1997;15,291-6.
33. Dhawan V, Kumar K, Marwaha RK, Ganguly NK. Antioxidant
status in children v.ith homozygous thalassemia. Indian Pediatr.
2005;42;1141-5.
34. Khaled MA. Oxidative stress in childhood malnutrition and
diarrhoeal diseases. J Diarrhoeal Dis Res. 1994; 12:165􀁢 72.
35. Arijanty L, Nasar SS, Madiyono B, Gatot D. Relationships
between plasma zinc and ferritin with nutritional status in
thalassemic children. Paediatr Indones. 2006;46:220A.
Published
2012-06-30
How to Cite
1.
Gunarsih A, Amalia P, Boediman I. Variables associated with malondialdehyde level in thalassemia major patients. PI [Internet]. 30Jun.2012 [cited 26Apr.2024];52(3):125-1. Available from: https://paediatricaindonesiana.org/index.php/paediatrica-indonesiana/article/view/378
Issue
Vol 52 No 3 (2012): May 2012
Section
Articles

Authors who publish with this journal agree to the following terms:

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Received 2016-08-30
Accepted 2016-08-30
Published 2012-06-30